Skip to main content
Have a personal or library account? Click to login
Biomarkers and Their Potential Use in Transplantation Cover

References

  1. Anonymous (2001). Biomarker definition working group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework.,, 89-95.
  2. Akalin, E., Dinavahi, R., Friedlander, R., Ames, S., de Boccardo, G., Sehgal, V., Schroppel, B., Bhaskaran, M., Lerner, S., Fotino, M., Murphy, B., Bromberg, J. S. (2008). Addition of plasmapheresis decreased the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies..,, 1160-1167.
  3. Anglicheau, D., Suthanthiran, M. (2008). Noninvasive prediction of organ graft rejection and outcome using gene expression patterns.,, 192-199.
  4. Banon-Maneus, E., Diekmann, F., Carrascal, M., Quintana, L.F., Moya-Rull, D., Bescos, M., Ramírez-Bajo, M. J., Rovira, J., Gutierrez-Dalmau, A., Sole-Gonzalez, A., Abian, J., Campistol, J. M. (2010). Two-dimensional difference gel electrophoresis urinary proteomic profile in the search of nonimmune chronic allograft dysfunction biomarkers.,, 548-558.
  5. Bestard, O., Gruzado, J., Cassis, L., Franquesa, M., Cantarelli, C., Torras, J., Goma, M., Sawitzki, B., Volk, H., Reinke, P., Grinyo, J. (2011). Immune- monitoring of alloreactive memory/effector T-cell alloresponse for selection on CNI-free immunpsupression in renal transplantation.,, 395.
  6. Borozdenkova, S., Westbrook, J. A., Patel, V., Wait, R., Bolad, I., Burke, M. M., Bell, A. D., Banner, N. R., Dunn, M. J., Rose, M. L. (2004). Use of proteomics to discover novel markers of cardiac allograft rejection..,, 282-287.
  7. Brouard, S., Mansfield, E., Braud, C., Li, L., Giral, M., Hsieh, S. C., Baeten, D., Zhang, M., Ashton-Chess, J., Braudeau, C., Hsieh, F., Dupont, A., Pallier, A., Moreau, A., Louis, S., Ruiz, C., Salvatierra, O., Soulillou, J. P., Sarwal, M. (2007). Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance..,, 15448-15453.
  8. Calabuig, A., Guirado, L., Ramos, D. (2012). Prognostic significance and diagnosis of proteinuria in renal transplantation.,, 30-35.
  9. Coca, S., Yalavarthy, R., Concato, J., Parikh, C. (2008). Biomarkers for the diagnosis and risk stratification of acute kidney injury. A systematic review.,, 10081016
  10. Danovitch, G. (2010).. Lippincott: Williams and Wilkins. 471 pp.
  11. De Gruttola, V. G. (2001). Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of the National Institutes of Health workshop.,, 485-502.
  12. Einecke, G., Mengel, M., Reeve, J., Gwinner, W., Broecker, V., Haller, H., Halloran P.F. (2010). Molecular changes in renal allograft protocol biopsies reflect a stereotyped organization in injured or inflamed sites.,(Suppl 4), 62.
  13. Farid, W., Pan, Q., van der Meer, A. (2011). Hepatocyte-derived microRNA in human serum are sensitive markers for hepatic injury in liver transplantation.,(Suppl 2), 389.
  14. Flechner, S. M., Kurian, S. M., Head, S. R., Sharp, S. M., Whisenant, T. C., Zhang, J., Chismar, J. D., Horvath, S., Mondala, T., Gilmartin, T., Cook, D.J., Kay, S. A., Walker, J. R., Salomon, D. R. (2004). Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes..,, 1475-1489.
  15. Foster, C., Cooper, C. (2009). Urgent need develop independent biomarkers for functional, diagnostic and prognostic application in oncology research.,, 329-333.
  16. Gillespie, A., Lee, I. (2008). Biomarkers in renal transplantation.,, 603-612.
  17. Graetz, K., Inston, N., Rigg, K. (2009). The donor procedure. In:. Forsythe, J. (ed.). Saunders Ltd., Edinburgh, pp. 101-124.
  18. Halloran, Ph. (2010). Individualizing immunosuppressive therapy: Opportunities to manage risk.,(Suppl.1), 48.
  19. Henderson, L., Nankivell, B., Chapman, J. (2011). Surveillance protocol kidney transplant biopsies: Their evolving role in clinical practice.,, 1570-1575.
  20. Ho, J., Rush, D., Karpinsky, M., Storsley, L., Gibson, J., Stefura, W., Hayglass, K., Nickerson, P. (2010) Urinary MCP1 at 6 month correlates with development of interstitial fibrosis and tubular atrophy at 24 month in renal allograft.,(Suppl 4): 60.
  21. Ho, J., Rush, D., Bestland, J., Gao, A., Karpinsky, M., Storsley, L., Gibson, J., Nickerson, P. (2011). Validation of urinary CXCL10 as a maker of borderline, subclinical and clinical tubulitis.,(Suppl 2), 387.
  22. Hollmen, M., Kyllonen, L., Inkenen, K., Lalla, M. L., Salmela, K. T. (2011). Urine neutrophil gelatinase associated lipokalin is a marker of graft recovery after kidney transplantation.,, 89-98.
  23. Hricik, D. (2011).. Blackwell, West Sussex: Wiley. 307 pp.
  24. Johnson, M., Kao, W., Winkel, E. (2011). Heart transplantation. In:Hricik, D. (ed.). Wiley-Blackwell, West Sussex, pp. 171-204.
  25. Jahnukainen, T., Malehorn, D., Sun, M., Lyons-Weiler, J., Bigbee, W., Gupta, G., Shapiro, R., Randhawa, P. S., Pelikan, R., Hauskrecht, M., Vats, A. (2006). Proteomic analysis of urine in kidney transplant patients with BK virus nephropathy..,, 3248-3252.
  26. Jushinskis, J., Amerika, D., Suhorukovs, V., Trushkovs, S., Maltsevs, A., Rozental, R. (2011). Urine NGAL as a biomarker for evaluation of deceased kidney donors.,, 273.
  27. Klienzl-Wagner, K., Pratschke, J., Brandacher, G. (2011). Proteomics- a blessing or curse? Application of proteomics technology to transplant medicine.,, 499-509.
  28. Loupy, A., Hill, G., Suberbielle, C., Charron, D., Anglicheau, D., Zuber, J., Timsit, M., Bruneval, P., Empans, J., Jouven, X., Legendre, C. (2011).. Significance of CD4 Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA).,, 56-65.
  29. Matar, M., Nguyen, M., Aljiffry, M., Salman, A., Aikins, R., Paraskevas, S. (2011). HMGB-1 and HSP-70 in mechanically preserved kidney allograft as markers of long term function.,(Suppl 2), 383-384.
  30. Mba, M., Maluf, D., Dumer, S., Scian, M., Posner, M., King, A., Gehr, B., Cotterell, A., Mas, R. (2011). Molecular biomarkers of human kidney transplant ischemia reperfusion injury.,(Suppl 2), 454.
  31. McIlroy, D., Wagener, G., Lee, H. (2010). Biomarkers in acute kidney injury: An evolving domain.,, 998-1004.
  32. Molnar, M., Kovesdy, C., Bunnapradist, S., Streja, E., Krishnan, M., Nisselson, A., Kalantar-Zadeh, K. (2011). Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients.,, 1006-1016.
  33. Mueller, T., Pedrycz, B., Comtson, C., Zhu, L., Andeson, C., Perkins, D., Luyckx, V. (2011). Oncostatin M and its receptors are key mediator of local and distant organ inflammation and injury after ischemia and reperfusion.,(Suppl 2), 389.
  34. Muthukumar, T., Mueller, F., Anglicheau, D., Sharma, V., Ding, R., Suthanthiran, M. (2011). Intragraft MicroRNA expression signatures of interstitial fibrosis and tubular atrophy of human renal allografts.,, 291.
  35. Nankivell, B. J., Chapmen, J. R. (2006). Chronic allograft nephropathy. Current concept and future direction.,, 643-654.
  36. Nickel, P., Presber, F., Bold, G., Biti, D., Schonemann, C., Tullius, S. G., Volk, H. D., Reinke, P. (2004). Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells indentifies T-cell presentation and correlates with graft function at 6 at 12 month in renal- transplant recipients., 1640-1646.
  37. Parikh, C., Jani, A., Mishra, J., Ma, Q., Kelly, C., Barasch, J., Edelstein, C. L., Devarajan, P. (2006). Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation..,, 1639-1645.
  38. Quintana, L. F., Sole-Gonzalez, A., Kalko, S. G., Banon-Maneus, E., Sole, M., Diekmann, F., Gutierrez-Dalmau, A., Abian, J., Campistol, J. M. (2009). Urine proteomics to detect biomarkers for chronic allograft dysfunction.,, 428-435.
  39. Reeve, J., Einecke, G., Mengel, M., Sis, B., Kayser, N., Kaplan, B., Halloran, P. (2009). Diagnosing rejection in renal transplants: A comparison of molecular and histopathology-based approaches.,, 180-1810.
  40. Roukos, D. (2010) Next generation, genome sequencing based biomarkers: Concerns and challenges for medical practice.,, 583-586.
  41. Sagoo, P., Perucha, E., Sawitzki, B., Tomiuk, S., Stephens, D. A., Miqueu, P., Chapman, S., Craciun, L., Sergeant, R., Brouard, S., Rovis, F., Jimenez, E., Ballow, A., Giral, M., Rebollo-Mesa, I., Le Moine, A., Braudeau, C., Hilton, R., Gerstmayer, B., Bourcier, K., Sharif, A., Krajewska, M., Lord, G. M., Roberts, I., Goldman, M., Wood, K. J., Newell, K., Seyfert-Margolis, V., Warrens, A. N., Janssen, U., Volk, H. D., Soulillou, J. P., Hernandez-Fuentes, M. P., Lechler, R. I. (2010). Development of a crossplatform biomarker signature to detect renal transplant tolerance in humans..,, 1848-1861.
  42. Shand, J. A., Menown, I. B., McEneaney, D. J. (2010). A timely diagnosis of myocardial infarction.,, 385-393.
  43. Snanoudj, R., Royal, V., Elie, C., Rabant, M., Girardin, C., Morelon, E., Kreis, H., Fournet, J. C., Noel, L. H., Legendre, C. (2011). Specificity of histological markers of long term CNI nephrotoxicity in kidney transplant recipient under low-dose cyclosporine therapy..,, 2635-2646.
  44. Sprangers, B., Kuypers, D., Vanrenterghem, Y. (2011). Immunosupression: Does one regimen fit all.,, 251-261.
  45. Stock, P., Kirk, A. (2011). The risk and opportunity of homeostasis repopulation.,, 1349-1350.
  46. Suthanthiran, M., Ding, R., Sharma, V., Abecassis, M., Samstein, B., Knechtle, S., Hascock, W., Han, L., Liu, J., Shaked, A. (2011). Urinary cell messenger RNA expression signatures anticipate acute cellular rejection.,(Suppl 2), 29.
  47. Tyres, M., Mann, M. (2006). From genomics to proteomics.,, 193-196.
  48. Vasan, R. S. (2006). Biomarkers of cardiovascular disease: Molecular basis and practical considerations.,, 2335-2362.
  49. Waikar, S., Betensky, R., Emerson, S., Bonventre, J. (2012). Imperfect gold standards for kidney injury biomarker evolution.,, 13-21.
  50. Waldman, S., Terzic, A. (2011). Patient-centric clinical pharmacology advances the path to personalized medicine.,, 607-700.
  51. Zou, Y., Stastny, P., Susal, C., Dohler, B., Opelz, G. (2007). Antibodies against MICA antigens and kidney-transplant rejection.,, 1293-1300.
DOI: https://doi.org/10.2478/v10046-012-0013-0 | Journal eISSN: 2255-890X (formerly 1407-009X) | Journal ISSN: 1407-009X
Language: English
Page range: 219 - 268
Published on: May 1, 2013
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services

© 2013 Rafails Rozentals, Jānis Jušinskis, Diana Amerika, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.